Skip to main content
Cannabix Technologies Inc logo

Cannabix Technologies Inc — Investor Relations & Filings

Ticker · BLO LEI · 529900ELT8R2ZTQS9H10 CSE Manufacturing
Filings indexed 169 across all filing types
Latest filing 2025-05-09 Regulatory Filings
Country CA Canada
Listing CSE BLO

About Cannabix Technologies Inc

https://cannabixtechnologies.com/

Cannabix Technologies Inc. develops innovative, non-invasive breath testing and screening technologies for detecting and quantifying substance impairment. The company specializes in creating reliable tools for measuring THC (tetrahydrocannabinol) in breath, serving law enforcement and workplace safety needs by providing an alternative to outdated marijuana testing methods. Cannabix also offers fully automated, contactless breath alcohol screening systems. These cutting-edge solutions enhance safety and compliance by delivering efficient and accessible tools for drug and alcohol testing.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a TSX Trust Company administrative notice confirming that CANNABIX TECHNOLOGIES INC. has sent its Notice of Record and Meeting Dates for an upcoming Annual General and Special Meeting of Security Holders. It does not contain AGM materials or the proxy statement itself, nor does it announce voting results or financial figures. Rather, it is a routine regulatory notice filed with exchanges and commissions. There is no dedicated “Notice of Meeting” category, so it defaults to a general regulatory announcement category.
2025-05-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing a non-exclusive distribution agreement and providing product and forward-looking information. It is not a financial report (10-K, IR, ER), not an AGM/EGM materials, not an earnings release, not a management change, not a financing or capital structure notice, and not any of the specific filings listed. It has the structure of a general regulatory announcement or press release. Therefore, it is best classified under the fallback category: Regulatory Filings (RNS).
2025-04-28 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release rather than an actual financial report. It primarily announces attendance at a conference and a change of auditor, and does not itself contain an audit report, financial statements, or detailed governance documentation. No specific category (e.g., earnings release, annual report, management change) precisely fits, so it falls under the general “Regulatory Filings” fallback category.
2025-04-07 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing Cannabix’s attendance at a drug and alcohol conference to market its marijuana breath test and reporting a laboratory validation milestone. It contains corporate marketing and operational updates, forward-looking statements, and no financial results, no regulatory form numbers (e.g., 10-K, IR, DEF 14A), no share transactions, and no dividend or voting details. It does not fit any specific category like earnings release, annual or interim report, capital change, management change, or M&A. Therefore it falls into the general “Regulatory Filings” fallback category for miscellaneous corporate news announcements (RNS).
2025-04-01 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian NI 51-102 Form 51-102F3 “Material Change Report,” which is a continuous disclosure regulatory filing notifying investors of a director resignation and stock option grant. It is not a full annual or interim report, earnings release, or AGM material, but rather a general regulatory announcement. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2025-03-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a standard corporate news release/press announcement regarding a product development collaboration and validation results. It does not present financial statements (so not ER, IR, or 10-K), nor does it cover board changes, dividends, share issues, or legal proceedings. It is also not a formal investor presentation or report; rather it is a general announcement and thus best fits the fallback “Regulatory Filings” category (RNS).
2025-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.